Original Research
Published on 14 Oct 2022
Aberrantly hypermethylated ARID1B is a novel biomarker and potential therapeutic target of colon adenocarcinoma
in Cancer Genetics and Oncogenomics
- 4,359 views
- 5 citations
Original Research
Published on 14 Oct 2022
in Cancer Genetics and Oncogenomics
Original Research
Published on 13 Oct 2022
in Cancer Genetics and Oncogenomics
Original Research
Published on 13 Oct 2022
in Cancer Genetics and Oncogenomics
Original Research
Published on 12 Oct 2022
in Cancer Genetics and Oncogenomics
Original Research
Published on 12 Oct 2022
in Cancer Genetics and Oncogenomics
Review
Published on 12 Oct 2022
in Cancer Genetics and Oncogenomics
Original Research
Published on 12 Oct 2022
in Cancer Genetics and Oncogenomics
Original Research
Published on 11 Oct 2022
in Cancer Genetics and Oncogenomics
Original Research
Published on 11 Oct 2022
in Cancer Genetics and Oncogenomics
Original Research
Published on 11 Oct 2022
in Cancer Genetics and Oncogenomics
Editorial
Published on 10 Oct 2022
in Cancer Genetics and Oncogenomics
Original Research
Published on 10 Oct 2022
in Cancer Genetics and Oncogenomics
Original Research
Published on 10 Oct 2022
in Cancer Genetics and Oncogenomics
Original Research
Published on 10 Oct 2022
in Cancer Genetics and Oncogenomics
Original Research
Published on 07 Oct 2022
in Cancer Genetics and Oncogenomics
Original Research
Published on 07 Oct 2022
in Cancer Genetics and Oncogenomics
Correction
Published on 07 Oct 2022
in Cancer Genetics and Oncogenomics
Original Research
Published on 06 Oct 2022
in Cancer Genetics and Oncogenomics
Original Research
Published on 06 Oct 2022
in Cancer Genetics and Oncogenomics
Original Research
Published on 06 Oct 2022
in Cancer Genetics and Oncogenomics
Original Research
Published on 06 Oct 2022
in Cancer Genetics and Oncogenomics
Original Research
Published on 06 Oct 2022
in Cancer Genetics and Oncogenomics
Original Research
Published on 06 Oct 2022
in Cancer Genetics and Oncogenomics
Original Research
Published on 05 Oct 2022
in Cancer Genetics and Oncogenomics